Questions? +1 (202) 540-8337 Login
Trusted News Since 1995
A service for medical industry professionals · Tuesday, October 16, 2018 · 465,302,515 Articles · 3+ Million Readers

Global Tissue Diagnostics Market Research and Forecast, 2018-2023

Orion Market Research Pvt. Ltd.

Industry Market Research Report and Consulting

Global Tissue Diagnostics Market, Size, Share, Market Intelligence, Company Profiles, Market Trends, Strategy, Analysis, Forecast 2018-2023

Rise in cancer patients, adoption of personalized healthcare and FDA clearances are the key driving forces of global tissue diagnostic market”
— OMR Analyst

INDORE, INDIA, March 13, 2018 / -- Orion Market Research (OMR), recently published a market research report on global tissue diagnostic market. According to the OMR analysis the global tissue diagnostic market is expected to grow with a CAGR of 7.7% during 2018-2023. The global tissue diagnostic market is segmented on the basis of technology, diagnosis, product, end user and geography. The report provides detailed and insightful chapters on market overview, key findings, strategic recommendations, gap analysis, market estimations, market determinants, pipeline analysis, key company analysis, market insights, company profiling, market segmentation, geographical analysis, analyst insights and predictive analysis of the market.

The full report of global tissue diagnostic market is available at

“The global tissue diagnostic market is triggered by the rising incidence and prevalence rate of Cancer and adoption of in-vitro diagnostics across the globe. Tissue diagnostics have led to more accurate identification and detection of cancer tissues due technologies such as immunohistochemistry (IHC), in-situ hybridization. The emergence of digital pathology which includes use of computer technology for more detailed presentation of the patient data and workflow management which helps in controlled and effective process flow are other key technologies which have resulted in higher efficiency in diagnostics. High investment in R&D by tissue diagnostic manufacturing companies such as Roche Holding AG, Biogenex Laboratories, Alere and so on are creating scope in global tissue diagnostic market. Funding from government and private players are expected to boost Global Tissue Diagnostic Market in near future. “

The high cost of tissue diagnostic devices and treatment are concern for the market. However, the rising demand for tissue diagnostic products such as slide staining system, scanners, tissue processing systems, kits and reagents have created scope for the market.

The Asia Pacific is the fastest growing market regionally. It also has the highest share with 31.8% market share. The market growth is driven by high prevalence of cancer, decline in the social stigma related to breast and prostate cancer, availability of private insurance, increase in the number of diagnostic centres and super specialty hospitals. China, India and Japan will be highest revenue generating markets. China has shown exponential growth in the diagnostics market. The investments have been in a rise. China has also become the hub for contract research organization with over 200 CRO’s in the country. Availability of low-cost instruments and consumables is also a major factor.

North America has the second highest market share in the global tissue diagnostics market with 31% market share. The North American market is driven primarily by the growth in the U.S. Also, the amount of investment in the research and development in the drug discovery, personalized medicines research and cancer diagnostic is significantly high the U.S. Even the Canadian market has high investment in the cancer diagnostics. Canada also offers public health services which allows more number of patients to opt for expensive tissue diagnostic foe the diagnosis of cancer. Awareness regarding breast and prostate cancer in North America is very high. There is constantly some campaign going on to promote the awareness regarding the cancer. Some of the top non-healthcare companies run CSR campaigns to increase the awareness. Even the policies regarding insurance and reimbursements are well framed and beneficial in the North American region which allow patients to go for the tissue diagnostics.

Companies Profiled:
• Agilent
• Alere
• Axxin
• Becton Dickinson & Company
• Bio SB
• Biocept
• Biogenex Laboratories
• Biomeriux
• Caris Life Sciences
• Cell Signalling Technology, Inc.
• DiaGenic
• Eurogentec
• GE Healthcare
• Grifols Diagnostic Solutions Inc.
• Johnson & Johnson
• Novodiax
• Philips Healthcare
• Prometheus Laboratories Inc.
• Qiagen
• Quest Diagnostic
• Ribomed
• Roche Holdings AG
• Siemens
• Singulex
• Teco Diagnostics
• Trinity Biotech

About Orion Market Research
Orion Market Research (OMR) is an Indian research company known for its crisp and concise reports. We are equipped with an experienced team and young brigade of analysts. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. OMR provides global and regional market reports of various domains such as healthcare, energy, IT, chemicals, and automobiles. OMR provides a 360-degree view of the market with parametric analysis, key market insights, key findings, statistical forecasts, competitive landscape, extensive segmentation, key trends, strategic recommendations and detailed company profiles.

Anurag Tiwari
Orion Market Research Pvt. Ltd.
email us here

Powered by EIN Presswire